Eric H. Bjerkholt
A senior executive with more than two decades of experience in the healthcare and life science sectors, Mr. Bjerkholt is the Chief Financial Officer of Aimmune Therapeutics, Inc., a biotechnology company developing treatments for food allergies. From 2004 to 2017, he was Executive Vice President, Corporate Development and Finance and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company developing oncology therapeutics. From 2002 to 2004, he was Senior Vice President and Chief Financial Officer at IntraBiotics Pharmaceuticals, Inc., which was a biopharmaceutical company that was acquired by Ardea Biosciences, Inc. in December 2006. Mr. Bjerkholt was a co-founder of LifeSpring Nutrition, Inc., a nutraceutical company, and from 1999 to 2002 served at various times as its Chief Executive Officer, President, and Chief Financial Officer. He also served as a vice president in the healthcare banking group at J.P. Morgan & Co. Incorporated from 1990 to 1997. He holds a Cand. Oecon degree in Economics from the University of Oslo and an M.B.A. from Harvard Business School.